Where to invest $10,000 in ASX shares right now

Man looking amazed holding $50 Australian notes, representing ASX dividends.

If you have $10,000 ready to invest, the current market volatility could be creating some interesting opportunities.

Recent weakness, particularly across growth and quality names, has seen a number of high-performing companies trade well below their highs.

For investors with a long-term mindset, this could be a chance to build positions in businesses with strong fundamentals at more attractive prices.

Here are three ASX shares that could be worth considering right now.

Goodman Group (ASX: GMG)

The first ASX share that could be a top option for a $10,000 investment is Goodman Group.

The industrial property giant focuses on logistics and warehouse assets, which are critical infrastructure for ecommerce and global supply chains.

Furthermore, Goodman has a growing presence in data centres. In fact, at the last count, its global power bank increased to 6.0 GW across 16 major global cities. This leaves it well-positioned to benefit from increasing demand for digital infrastructure.

Goodman’s model combines development, management, and ownership of assets, which allows it to generate multiple income streams. Its strong balance sheet and access to capital also support ongoing expansion.

With structural tailwinds from both ecommerce and data usage firmly in its sails, Goodman appears well placed for long-term growth.

Pro Medicus Ltd (ASX: PME)

Another ASX share that could be worth considering is Pro Medicus.

The health imaging technology company provides software used by hospitals and radiologists. Its best-in-class Visage 7 suite of products are the foundation of an ultra-fast, clinically rich, and highly scalable platform that can seamlessly be implemented in both public and private cloud environments.

Unsurprisingly, due to the quality of its Visage platform, Pro Medicus continues to win major contracts. This includes a $40 million contract announced this month

And with a capital-light model and high margins, much of this revenue falls straight to the bottom line.

Overall, with increasing demand for advanced medical imaging and digital healthcare solutions, Pro Medicus appears well-placed for long-term growth.

Xero Ltd (ASX: XRO)

A final ASX share to consider for a $10,000 investment is Xero.

It offers cloud-based accounting software to small and medium-sized businesses, helping them manage everything from invoicing to payroll.

Its subscription-based model provides recurring revenue and strong visibility over future earnings. In addition, Xero has opportunities to grow through international expansion and by increasing the number of services offered to its users.

The company has a significant total addressable market, estimated in the region of 100 million users globally. So, with around 4.5 million users currently, it has a long growth runway.

The post Where to invest $10,000 in ASX shares right now appeared first on The Motley Fool Australia.

Should you invest $1,000 in Goodman Group right now?

Before you buy Goodman Group shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Goodman Group wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor James Mickleboro has positions in Goodman Group, Pro Medicus, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Goodman Group and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.